{"id":"F2006L03361","name":"Therapeutic Goods (Listing) Notice 2006 (No. 4)","slug":"therapeutic-goods-listing-notice-2006-no-4","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":60758,"registerId":"commonwealth-F2006L03361-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2006 (No. 4)","content":"![](image.001.png)\n\nTherapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2006 (No. 4)\n\nI, DAVID GRAHAM, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (ARTG) for listed goods:\n\n-   preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990, for oral use that contain, as their therapeutically active ingredient, Concentrated omega-3 triglycerides-fish, the substance described in the monograph of the British Pharmacopoeia 2005 as Omega-3-Marine Triglycerides, being a substance that is to be mentioned in Division 1 of Part 5 of Schedule 4 of the Therapeutic Goods Regulations 1990.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act this Notice ceases to have effect on the day that amendments to the Therapeutic Goods Regulations 1990 come into effect to require inclusion of the substance listed in this Notice in the part of the ARTG for listed goods.\n\nDated this tenth day of October 2006\n\nDr David Graham\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1959},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The notice maintains a narrow, targeted scope limited to the administrative listing of one specific therapeutic substance. It functions exactly as intended—a discrete, temporary delegation instrument pending formal regulatory amendment."},"complexity_factors":["Single operative provision authorising one specific substance","Temporary mechanism with automatic sunset clause under subsection 9A(6)","Precise technical references to British Pharmacopoeia monograph standards","Cross-referencing to specific items and divisions within Schedule 4 of the parent Regulations"],"plain_english_summary":"This notice temporarily permits oral fish oil supplements containing \"Concentrated omega-3 triglycerides‑fish\" (BP2005) to be listed on the Australian Register of Therapeutic Goods, allowing them to be sold as listed (over‑the‑counter) medicines. It affects manufacturers/importers who must list products to sell and consumers seeking access, and it matters because it provides a legal pathway to market these products immediately while permanent regulatory amendments are prepared."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2006-no-4","history":"/api/acts/therapeutic-goods-listing-notice-2006-no-4/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2006-no-4/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2006-no-4/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2006-no-4/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2006-no-4/documents"}}